TrialDiabetes, obesity & metabolism2026

A double-blind study on ulotaront's impact on weight-related parameters in schizophrenia patients with metabolic syndrome and prediabetes: Part II.

Snezana Milanovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.